HFpEF Drug Discovery & Development Summit 2022
Taking place this January in Boston, the HFpEF Drug Discovery & Development Summit 2022 is the first and only devoted meeting uniting large pharma, biotech, and pioneering academics under the mutual and ambitious objective of accelerating the practical discovery, translation, and clinical development of safe, effective and deliverable therapies to treat HFpEF, an extremely common heart failure with a huge unmet medical need.
Join 80+ experts at this ground-breaking forum with the likes of AstraZeneca, Eli Lilly, Bayer, Amgen, Novartis, and many more sharing state-of-the-art insights and expertise in heart failure. Covering topics including specific and applied drug development hurdles with inadequate successful treatments, such as the translational challenges between phases of pre-clinical and clinical trials, this is a conversation not to miss.
Attending this summit will equip you with the information and partnerships to succeed and translate drug candidates into human clinical trials, whilst optimizing your clinical development process itself to evade further clinical failures.